Key Insights

Highlights

Treatment Research

4 treatments under study, led by Pulmonary Function Test

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2/3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06856525Phase 2/3RecruitingPrimary

Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology

Showing all 1 trials

Research Network

Common Treatments

  • Pulmonary Function Test1
  • Chest Ct1
  • Hyperpolarized Xenon 1291
  • Cardiopulmonary Stress Test1

Active Sponsors

  • Y. Michael Shim, MD1
  • George Mason University1
  • Duke University1

Top Investigators

Activity Timeline